Hepatitis C treatment outcomes among homeless-experienced individuals at a community health centre in Boston

被引:55
作者
Beiser, Marguerite E. [1 ]
Smith, Kamala [1 ]
Ingemi, Molly [1 ]
Mulligan, Emma [1 ]
Baggett, Travis P. [1 ,2 ,3 ]
机构
[1] Boston Hlth Care Homeless Program, Inst Res Qual & Policy Homeless Hlth Care, 780 Albany St, Boston, MA 02118 USA
[2] Massachusetts Gen Hosp, Div Gen Internal Med, 55 Fruit St, Boston, MA 02114 USA
[3] Harvard Med Sch, Dept Med, 25 Shattuck St, Boston, MA 02115 USA
关键词
Homelessness; Hepatitis C; Injection drug user; VIRUS-INFECTION; MENTAL-ILLNESS; PEOPLE; CARE; HCV; PREVALENCE; SOFOSBUVIR; ADULTS; HIV;
D O I
10.1016/j.drugpo.2019.03.017
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Hepatitis C virus (HCV) infection prevalence is high among adults who experience homelessness but data on HCV treatment outcomes are limited in this population. We examined HCV treatment engagement and outcomes in a cohort of homeless-experienced adults treated through an innovative community-based primary care program in Boston, Massachusetts, USA. Methods: We conducted a retrospective chart review of individuals referred for HCV treatment at Boston Health Care for the Homeless Program (BHCHP) from January 2014 to March 2017. We assessed HCV treatment initiation, treatment completion, sustained virologic response (SVR), and reinfection rates. We conducted univariate and multivariable logistic regression analyses to examine the predictors of these outcomes. Results: Of 510 referred for HCV treatment, 210 (41.1%) did not initiate treatment, principally because of being lost to follow-up (N = 93) or having superseding social issues (N = 49). Of 300 who initiated treatment, 80% were male, 52.3% were non-white, and 29% were homeless. Over half (58.6%) had a history of opioid use disorder (OUD). Twenty percent had cirrhosis. Treatment was completed by 285 (95.0%) individuals, and 255 (85.0%) achieved SVR. In multivariable analyses, individuals with bipolar disorder (OR 0.38, 95% CI 0.15 - 0.99), treated (OR 0.36, 95% CI 0.14 - 0.96) or untreated (OR 0.18, 95% CI 0.05 - 0.57) OUD, or ontreatment insurance change (OR 0.16, 95% CI 0.04 - 0.67) were less likely to achieve SVR, while individuals living with HIV (OR 10.43, 95% CI 1.33-81.96) were more likely to achieve SVR. Among 126 individuals with post-SVR follow-up data, 27 reinfection were identified during 206 person-years of follow up (rate 13.1 per 100 person-years). Conclusion: Homeless-experienced individuals initiating HCV treatment in a community-based program achieved high rates of treatment completion and SVR, but a large proportion did not initiate treatment. Individuals with OUD experienced lower but still substantial rates of cure. Treatment strategies targeting homeless-experienced people should focus on improving initial engagement and minimizing reinfection risk following treatment.
引用
收藏
页码:129 / 137
页数:9
相关论文
共 23 条
[1]   Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers [J].
Arora, Sanjeev ;
Thornton, Karla ;
Murata, Glen ;
Deming, Paulina ;
Kalishman, Summers ;
Dion, Denise ;
Parish, Brooke ;
Burke, Thomas ;
Pak, Wesley ;
Dunkelberg, Jeffrey ;
Kistin, Martin ;
Brown, John ;
Jenkusky, Steven ;
Komaromy, Miriam ;
Qualls, Clifford .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (23) :2199-2207
[2]   Subsistence difficulties are associated with more barriers to quitting and worse abstinence outcomes among homeless smokers: evidence from two studies in Boston, Massachusetts [J].
Baggett, Travis P. ;
Yaqubi, Awesta ;
Berkowitz, Seth A. ;
Kalkhoran, Sara M. ;
McGlave, Claire ;
Chang, Yuchiao ;
Campbell, Eric G. ;
Rigotti, Nancy A. .
BMC PUBLIC HEALTH, 2018, 18
[3]   Mortality Among Homeless Adults in Boston Shifts in Causes of Death Over a 15-Year Period [J].
Baggett, Travis P. ;
Hwang, Stephen W. ;
O'Connell, James J. ;
Porneala, Bianca C. ;
Stringfellow, Erin J. ;
Orav, E. John ;
Singer, Daniel E. ;
Rigotti, Nancy A. .
JAMA INTERNAL MEDICINE, 2013, 173 (03) :189-195
[4]   Experience and Outcomes of Hepatitis C Treatment in a Cohort of Homeless and Marginally Housed Adults [J].
Barocas, Joshua A. ;
Beiser, Marguerite ;
Leon, Casey ;
Gaeta, Jessie M. ;
O'Connell, James J. ;
Linas, Benjamin P. .
JAMA INTERNAL MEDICINE, 2017, 177 (06) :880-882
[5]   Using Publicly Available Data to Understand the Opioid Overdose Epidemic: Geospatial Distribution of Discarded Needles in Boston, Massachusetts [J].
Bearnot, Benjamin ;
Pearson, John F. ;
Rodriguez, Jorge A. .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2018, 108 (10) :1355-1357
[6]   Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis [J].
Beijer, Ulla ;
Wolf, Achim ;
Fazel, Seena .
LANCET INFECTIOUS DISEASES, 2012, 12 (11) :859-870
[7]   Effectiveness of All-Oral Antiviral Regimens in 996 Human Immunodeficiency Virus/Hepatitis C Virus Genotype 1-Coinfected Patients Treated in Routine Practice [J].
Bhattacharya, Debika ;
Belperio, Pamela S. ;
Shahoumian, Troy A. ;
Loomis, Timothy P. ;
Goetz, Matthew B. ;
Mole, Larry A. ;
Backus, Lisa I. .
CLINICAL INFECTIOUS DISEASES, 2017, 64 (12) :1711-1720
[8]   Hepatitis C Treatment: Clinical Issues for Psychiatrists in the Post-Interferon Era [J].
Chasser, Yvonne ;
Kim, Arthur Y. ;
Freudenreich, Oliver .
PSYCHOSOMATICS, 2017, 58 (01) :1-10
[9]   Modelling the impact of a national scale-up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland [J].
Fraser, Hannah ;
Mukandavire, Christinah ;
Martin, Natasha K. ;
Goldberg, David ;
Palmateer, Norah ;
Munro, Alison ;
Taylor, Avril ;
Hickman, Matthew ;
Hutchinson, Sharon ;
Vickerman, Peter .
ADDICTION, 2018, 113 (11) :2118-2131
[10]   Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial [J].
Grebely, Jason ;
Dalgard, Olav ;
Conway, Brian ;
Cunningham, Evan B. ;
Bruggmann, Philip ;
Hajarizadeh, Behzad ;
Amin, Janaki ;
Bruneau, Julie ;
Hellard, Margaret ;
Litwin, Alain H. ;
Marks, Philippa ;
Quiene, Sophie ;
Siriragavan, Sharmila ;
Applegate, Tanya L. ;
Swan, Tracy ;
Byrne, Jude ;
Lacalamita, Melanie ;
Dunlop, Adrian ;
Matthews, Gail V. ;
Powis, Jeff ;
Shaw, David ;
Thurnheer, Maria Christine ;
Weltman, Martin ;
Kronborg, Ian ;
Cooper, Curtis ;
Feld, Jordan J. ;
Fraser, Chris ;
Dillon, John F. ;
Read, Phillip ;
Gane, Ed ;
Dore, Gregory J. .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (03) :153-161